IRF2BP2 and hepatocellular carcinoma: Interestingly, IRF2BP2 overexpression in two hepatocellular carcinoma (HCC) cell lines (HepG2 and Huh7 cells) negatively regulated YAP activity and decreased the expression levels of YAP target genes.